Journals / Astım Allerji İmmünoloji / 2021 / Cilt: 19 - Sayı: 1

Pros and Cons of Nebulizer Treatment in Asthma Exacerbation During the COVID-19 Pandemic

Pages
1–5
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we aimed to assess the safetyin addition to the “pro” and “con” sides of nebulizer treatment in asthma exacerbation during the COVID-19 pandemic.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Nebulizers generate aerosols and may potentially transmit respiratory viral particles including SARS-CoV-2.
📊
Key Findings & Data:There is a great concernabout the use of a nebulizer in the treatment of asthma exacerbations in the hospital or home setting during the COVID-19 pandemicand its use is not recommended unless essential.
💡
Conclusion & Impact:In this article, we aimed to assess the safetyin addition to the “pro” and “con” sides of nebulizer treatment in asthma exacerbation during the COVID-19 pandemic.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Nebulizers generate aerosols and may potentially transmit respiratory viral particles including SARS-CoV-2. There is a great concernabout the use of a nebulizer in the treatment of asthma exacerbations in the hospital or home setting during the COVID-19 pandemicand its use is not recommended unless essential. However, aerosol therapy should not be avoided in obligatory indications. Therefore,indications of nebulizer use during the pandemic should be evaluated on an individual basis in case of a severe asthma attack, andinfection control recommendations should be followed by clinicians while using nebulizers. In this article, we aimed to assess the safetyin addition to the “pro” and “con” sides of nebulizer treatment in asthma exacerbation during the COVID-19 pandemic.

🔖

Cite This Article

ÖZTÜRK, A. B., BACCIOĞLU, A., SOYER, Ö., CİVELEK, E., ŞEKEREL, B. E., BAVBEK, S. (2021). Pros and Cons of Nebulizer Treatment in Asthma Exacerbation During the COVID-19 Pandemic. Astım Allerji İmmünoloji, Cilt: 19 - Sayı: 1, 1–5. https://ajindex.com/articles/351208

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Global strategy for asthma management and prevention. Global Initiative for Asthma Web site. http://www.ginasthma. org. Updated 2020. Accessed December 20, 2020
  2. Türkiye Ulusal Allerji ve Klinik İmmünoloji Derneği ve Türk Toraks Derneği. Astım Tanı ve Tedavi Rehberi 2020 Güncellemesi. Çelik G (ed). Aralık 2020
  3. Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, et al; American College of Chest Physicians; American College of Asthma, Allergy, and Immunology. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005;127(1):335-71
  4. Ozturk AB, Baççıoğlu A, Soyer O, Civelek E, Şekerel BE, Bavbek S. Change in allergy practice during the COVID-19 pandemic. Int Arch Allergy Immunol 2021;182(1):49-52
  5. Amirav I, Newhouse MT. Transmission of coronavirus by nebulizer: A serious, underappreciated risk. CMAJ 2020;192:E346
  6. Soyer Ö, Kahveci M, Büyüktiryaki B, Arık Yılmaz E, Karaatmaca B, Esenboğa S, et al. Mesh nebulizer is as effective as jet nebulizer in clinical practice of acute asthma in children. Turk J Med Sci 2019;49(4):1008-13
  7. Hui DS, Chow BK, Chu LC, Ng SS, Hall SD, Gin T, et al. Exhaled air and aerosolized droplet dispersion during application of a jet nebulizer. Chest 2009;135:648-54
  8. Liu Y, Ning Z, Chen Y, Guo M, Liu Y, Gali NK, et al. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals. Nature 2020;582:557-60
  9. Wan GH, Tsai YH, Wu YK, Tsao KC. A large volume nebulizer would not be an infectious source for severe acute respiratory syndrome. Infect Control Hosp Edidemiol 2004;25:1113-5. 10. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 2020;382(16):1564-7
  10. Heinzerling A, Stuckey MJ, Scheuer T, Xu K, Perkins KM, Resseger H, et al. Transmission of COVID-19 to health care personnel during exposures to a hospitalized patient - Solano County, California, February 2020. MMWR Morb Mortal Wkly Rep 2020:17;69(15):472-6
  11. Tang JW, Li Y, Eames I, Chan PKS, Ridgway GL. Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises. J Hosp Infect 2006;64:100– 14
  12. Tang JW, Kalliomaki P, Varila TM, Waris M, Koskela H. Nebulisers as a potential source of airborne virus. J Infect 2020; 81(4): 647–9
  13. Ari A. Use of aerosolised medi